Abstract 1503P
Background
Spirituality is important in cancer care. Few studies have assessed the spiritual needs (SN) of cancer patients. The purpose of this study was to assess the SN of patients undergoing curative or palliative cancer treatments, and to evaluate the relationship between SN and their health-related quality of life (QOL).
Methods
We conducted a cross-sectional study using a brief questionnaire on the healthcare team's approach to spirituality, the Duke University Religion Index (DUREL), the Functional Assessment of Chronic Illness Therapy Spiritual Well Being Version 4 (FACIT-SP), and the Spiritual Needs Assessment for Patients (SNAP) in outpatient adults with solid tumors undergoing curative-intent or palliative cancer treatments. Informed consent was obtained from all patients.
Results
From March to October/2022, 150 patients were included: 75 receiving curative-intent treatment and 75, palliative. Patients who wanted a spirituality approach by the healthcare team had higher total SN and psychosocial, spiritual, and religious scores than patients who did not want it (p < 0.0001), but lower QOL scores (FACIT-G p = 0.001 and FACIT-SP p = 0.004). SN or QOL did not differ according to treatment intention (p = 0,444 and p = 0,159 respectively), age (r = 0,059), education level (p = 0,999), sex (p = 0,186), or marital status (p = 0,528). There was a predominant weak correlation between SN and QOL (r < 0,4); a moderate negative relationship between emotional well-being and spiritual domain needs (r = -0,416); a weak correlation between SN and the three dimensions of DUREL (r < 0,4); a moderate positive relationship (0,461 < r < 0,616) between faith subscale of spiritual well-being and the three dimensions of DUREL; and also, a moderate positive relationship (r = 0,410) between spiritual well-being and intrinsic religiosity.
Conclusions
In our study, patients who wanted a spiritual approach from the healthcare team had higher SN and lower QOL. SN were not related to cancer treatment intentions or the patient religiosity. Assessment of spirituality may improve cancer care, and further studies could evaluate screening and interventions in this area.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1554P - Co payments in cancer patients: Analysis and estimating OOP
Presenter: Krishnamani Kalpathi
Session: Poster session 10
1555P - Estimating the social value of immuno-oncology (IO) therapies in Japan
Presenter: Tomoya Ohno
Session: Poster session 10
1556P - Current landscape of drug approvals for genitourinary (GU) cancers in North America and Europe
Presenter: Jose Tapia
Session: Poster session 10
1557P - The use of patient experience in UK NICE decision making in oncology
Presenter: Noemi Muszbek
Session: Poster session 10
1558P - Independent validation of the Breast Cancer Risk Assessment Tool (Gail model) for predicting breast cancer risk in Egyptian population
Presenter: Elaria Yacoub
Session: Poster session 10
1559P - Equity of access and clinical impact of genomic testing in patients with cancer in a UK early phase clinical trials unit
Presenter: Jonathan Poon
Session: Poster session 10
1560P - Optimal age versus real age in breast and gynaecological risk reducing surgery in BRCA1/2 carriers
Presenter: Alberta Ferrari
Session: Poster session 10
1561P - Targeted screening methodologies to select high risk individuals: LungFlag performance in Estonia Lung Cancer Screening Pilot
Presenter: Tanel Laisaar
Session: Poster session 10
1562P - The feasibility of polygenic risk score-based population screening for breast cancer: The experience from the BRIGHT study in Estonia
Presenter: Anni Lepland
Session: Poster session 10
1563P - Increasing the earlier detection of lung cancer: A toolbox for change
Presenter: Helena Wilcox
Session: Poster session 10